Two-period linear mixed effects models to analyze clinical trials with run-in data when the primary outcome is continuous: Applications to Alzheimer's disease

INTRODUCTION: Study outcomes can be measured repeatedly based on the clinical trial protocol before randomization during what is known as the “run-in” period. However, it has not been established how best to incorporate run-in data into the primary analysis of the trial. METHODS: We proposed two-per...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Alzheimers Dement (N Y)
Prif Awduron: Wang, Guoqiao, Aschenbrenner, Andrew J., Li, Yan, McDade, Eric, Liu, Lei, Benzinger, Tammie L.S., Bateman, Randall J., Morris, John C., Hassenstab, Jason J., Xiong, Chengjie
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Elsevier 2019
Pynciau:
Featured Article
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC6732759/
https://ncbi.nlm.nih.gov/pubmed/31517032
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.trci.2019.07.007
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg